Akademska digitalna zbirka SLovenije - logo
E-resources
Peer reviewed Open access
  • Mutant p53 cancers reprogra...
    Cooks, Tomer; Pateras, Ioannis S; Jenkins, Lisa M; Patel, Keval M; Robles, Ana I; Morris, James; Forshew, Tim; Appella, Ettore; Gorgoulis, Vassilis G; Harris, Curtis C

    Nature communications, 02/2018, Volume: 9, Issue: 1
    Journal Article

    TP53 mutants (mutp53) are involved in the pathogenesis of most human cancers. Specific mutp53 proteins gain oncogenic functions (GOFs) distinct from the tumor suppressor activity of the wild-type protein. Tumor-associated macrophages (TAMs), a hallmark of solid tumors, are typically correlated with poor prognosis. Here, we report a non-cell-autonomous mechanism, whereby human mutp53 cancer cells reprogram macrophages to a tumor supportive and anti-inflammatory state. The colon cancer cells harboring GOF mutp53 selectively shed miR-1246-enriched exosomes. Uptake of these exosomes by neighboring macrophages triggers their miR-1246-dependent reprogramming into a cancer-promoting state. Mutp53-reprogammed TAMs favor anti-inflammatory immunosuppression with increased activity of TGF-β. These findings, associated with poor survival in colon cancer patients, strongly support a microenvironmental GOF role for mutp53 in actively engaging the immune system to promote cancer progression and metastasis.